IGF1 and neoplasm: Since there are no known activating mutations for IGF1R, we generated a constitutively activated chimeric receptor that is capable of transforming NIH-3T3 cells into a rapidly growing xenograft flank tumor model that is shown to be exquisitely dependent upon IGF signal transduction.